Scanogen square logo ABOUT US

TECHNOLOGY

NEWS CAREERS CONTACT US
circuit

Technology

Scanogen is developing molecular diagnostic systems based on single molecule biosensors. These novel biosensors consist of DNA molecules and micron-sized particles that convert nucleic acid hybridization into an optical signal that can be detected using robust equipment. The bound target molecule is subjected to a disrupting force which allows for rapid detection with extremely low background noise. These biosensors enable detection of target molecules with high sensitivity and without the need of nucleic acid amplification.












home link
2016 Scanogen Inc.

3102 Lord Baltimore Dr., Suite 214, Baltimore, MD, 21244 | info@scanogen.com